|
| | Publication Year | Title | Author(s) |
| 321 | 22-Feb-2023 | Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer. | Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A; de Marinis, Filippo; John, Thomas ; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel |
| 322 | 2017 | Evaluation of Different Oligonucleotide Base Substitutions at CpG Binding sites in Multiplex Bisulfite-PCR sequencing. | Lu, Jennifer; Ru, Kelin; Candiloro, Ida L M; Dobrovic, Alexander ; Korbie, Darren; Trau, Matt |
| 323 | 29-Apr-2021 | Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy. | Klein, Oliver ; Kee, Damien ; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie ; Power, Daniel; Cebon, Jonathan S ; Behren, Andreas |
| 324 | 6-Jul-2017 | Evolution of anti-HER2 therapies for cancer treatment | Parakh, Sagun ; Gan, Hui K ; Parslow, Adam C; Burvenich, Ingrid JG; Burgess, Antony W; Scott, Andrew M |
| 325 | May-2021 | Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years. | Loh, Zoe ; Salvaris, Ross; Chong, Geoffrey ; Churilov, Leonid ; Manos, Kate ; Barraclough, Allison ; Hawkes, Eliza A |
| 326 | 1-Jun-2014 | Evolving role of tumor antigens for future melanoma therapies. | Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas |
| 327 | 17-Sep-2019 | Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin. | Rao, Devika; Mallick, Atrayee Basu; Augustine, Titto; Daroqui, Cecilia; Jiffry, Jeeshan; Merla, Amartej; Chaudhary, Imran; Seetharam, Raviraja; Sood, Arjun; Gajavelli, Srikanth; Aparo, Santiago; Rajdev, Lakshmi; Kaubisch, Andreas; Chuy, Jennifer; Negassa, Abdissa; Mariadason, John M ; Maitra, Radhashree; Goel, Sanjay |
| 328 | 26-Nov-2015 | Exemplary multiplex bisulfite amplicon data used to demonstrate the utility of Methpat. | Wong, Nicholas C; Pope, Bernard J; Candiloro, Ida; Korbie, Darren; Trau, Matt; Wong, Stephen Q; Mikeska, Thomas; van Denderen, Bryce J W; Thompson, Erik W; Eggers, Stefanie; Doyle, Stephen R; Dobrovic, Alexander |
| 329 | 1-Sep-2001 | Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation. | Luft, T; Rizkalla, M; Tai, T Y; Chen, Q; MacFarlan, R I; Davis, Ian D; Maraskovsky, Eugene; Cebon, Jonathan S |
| 330 | 13-Apr-2007 | The expanding role of PET technology in the management of patients with colorectal cancer. | Herbertson, R A; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 331 | 7-Aug-2023 | Experimental and spontaneous metastasis assays can result in divergence in clonal architecture. | Serrano, Antonin; Weber, Tom; Berthelet, Jean; El-Saafin, Farrah; Gadipally, Sreeja; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Mariadason, John M ; Oakes, Samantha R; Britt, Kara; Naik, Shalin H; Merino, Delphine |
| 332 | 12-Nov-2012 | Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies. | Starmans, Maud Hw; Pintilie, Melania; John, Thomas ; Der, Sandy D; Shepherd, Frances A; Jurisica, Igor; Lambin, Philippe; Tsao, Ming-Sound; Boutros, Paul C |
| 333 | 2021 | Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy. | Allam, Amr; Yakou, Marina; Pang, Lokman; Ernst, Matthias ; Huynh, Jennifer |
| 334 | 2021 | Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study. | Gates, Priscilla ; Dhillon, Haryana; Gough, Karla; Wilson, Carlene J ; Hawkes, Eliza A ; Scudder, Lindsay; Cushion, Tania; Krishnasamy, Meinir |
| 335 | 1-Aug-2003 | Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. | Tahtis, Kiki; Lee, Fook-Thean; Wheatley, Jennifer M; Garin-Chesa, Pilar; Park, John E; Smyth, Fiona E; Obata, Yuichi; Stockert, Elisabeth; Hall, Cathrine M; Old, Lloyd J; Rettig, Wolfgang J; Scott, Andrew M |
| 336 | Mar-2021 | Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival. | Chia, Puey Ling ; Parakh, Sagun ; Russell, Prudence; Gan, Hui K ; Asadi, Khashayar ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Liu, Zhanqi; Thapa, Bibhusal ; Scott, Fiona E; Scott, Andrew M ; John, Thomas |
| 17 | 14-Oct-2004 | Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. | Schnurr, Max; Toy, Tracey; Shin, Amanda; Wagner, Moritz; Cebon, Jonathan S ; Maraskovsky, Eugene |
| 18 | May-2022 | Factor Xa Inhibition for the Treatment of Venous Thromboembolism Associated With Cancer: A Meta-Analysis of the Randomised Controlled Trials. | Murphy, Alexandra C ; Koshy, Anoop N ; Farouque, Omar ; Yeo, Belinda ; Raman, Jaishankar; Kearney, Leighton G ; Yudi, Matias B |
| 19 | 1-Aug-2000 | The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. | Read, Stephen J; Hirano, T; Abbott, David F ; Markus, Romesh; Sachinidis, John I; Tochon-Danguy, Henri; Chan, J Gordon ; Egan, Gary F; Scott, Andrew M ; Bladin, Christopher; McKay, W J; Donnan, Geoffrey A |
| 20 | Nov-2018 | Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. | Shepshelovich, Daniel; Townsend, Amanda R; Espin-Garcia, Osvaldo; Latifovic, Lidija; O'Callaghan, Chris J; Jonker, Derek J; Tu, Dongsheng; Chen, Eric; Morgen, Eric; Price, Timothy J; Shapiro, Jeremy; Siu, Lillian L; Kubo, Michiaki; Dobrovic, Alexander ; Ratain, Mark J; Xu, Wei; Mushiroda, Taisei; Liu, Geoffrey |
